Dynavax Technologies Corp (DVAX) has a current Price-to-Book (P/B) ratio of NaN. Compared to its 3-year average P/B ratio of 2.57, the current P/B ratio is approximately NaN% higher. Relative to its 5-year average P/B ratio of 5.88, the current P/B ratio is about NaN% higher. Dynavax Technologies Corp (DVAX) has a Forward Free Cash Flow (FCF) yield of approximately NaN%. Compared to its 3-year average FCF yield of 5.07%, the current FCF yield is approximately NaN% lower. Relative to its 5-year average FCF yield of 6.71%, the current FCF yield is about NaN% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for DVAX competitors is 18538.96, providing a benchmark for relative valuation. Dynavax Technologies Corp Corp (DVAX.O) exhibits a P/S ratio of 4.70, which is -99.97% above the industry average. Given its robust revenue growth of 17.67%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of DVAX increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of DVAX in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is DVAX currently overvalued or undervalued?

Dynavax Technologies Corp (DVAX) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of -4.12. The fair price of Dynavax Technologies Corp (DVAX) is between -- to -- according to relative valuation method.

What is Dynavax Technologies Corp (DVAX) fair value?

DVAX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Dynavax Technologies Corp (DVAX) is between -- to -- according to relative valuation method.

How does DVAX's valuation metrics compare to the industry average?

The average P/S ratio for DVAX's competitors is 18538.96, providing a benchmark for relative valuation. Dynavax Technologies Corp Corp (DVAX) exhibits a P/S ratio of 4.70, which is -99.97% above the industry average. Given its robust revenue growth of 17.67%, this premium appears unsustainable.

What is the current P/B ratio for Dynavax Technologies Corp (DVAX) as of Mar 03 2026?

As of Mar 03 2026, Dynavax Technologies Corp (DVAX) has a P/B ratio of NaN. This indicates that the market values DVAX at NaN times its book value.

What is the current FCF Yield for Dynavax Technologies Corp (DVAX) as of Mar 03 2026?

As of Mar 03 2026, Dynavax Technologies Corp (DVAX) has a FCF Yield of NaN%. This means that for every dollar of Dynavax Technologies Corp's market capitalization, the company generates NaN cents in free cash flow.

What is the current Forward P/E ratio for Dynavax Technologies Corp (DVAX) as of Mar 03 2026?

As of Mar 03 2026, Dynavax Technologies Corp (DVAX) has a Forward P/E ratio of NaN. This means the market is willing to pay $NaN for every dollar of Dynavax Technologies Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Dynavax Technologies Corp (DVAX) as of Mar 03 2026?

As of Mar 03 2026, Dynavax Technologies Corp (DVAX) has a Forward P/S ratio of NaN. This means the market is valuing DVAX at $NaN for every dollar of expected revenue over the next 12 months.

DVAX Valuation